Listed

XBiotech Inc.

XBITNasdaqCIK 1626878HealthcareFiscal year ends Dec 31

Reports and events: 136 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

XBiotech Inc., Reports and events
FiledFormWhat it isAccession number
2017-03-1616:11 ET10-KAnnual reportPeriod 2016-12-310001171843-17-001571
2017-03-0315:38 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001171843-17-001289
2017-02-0811:19 ET8-K8.01 Other events0001171843-17-000749
2016-12-1612:48 ET8-K8.01 Other events0001171843-16-013675
2016-12-0720:16 ET8-K/A9.01 Financial statements and exhibits0001171843-16-013531
2016-12-0619:34 ET8-K/A9.01 Financial statements and exhibits0001171843-16-013509
2016-12-0516:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-013494
2016-11-1415:32 ET10-QQuarterly reportPeriod 2016-09-300001171843-16-013213
2016-09-2617:20 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001171843-16-012276
2016-08-1217:26 ET10-QQuarterly reportPeriod 2016-06-300001171843-16-011750
2016-06-2111:26 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001171843-16-010769
2016-05-2410:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-010277
2016-05-1317:15 ET10-QQuarterly reportPeriod 2016-03-310001171843-16-010052
2016-05-0314:45 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001171843-16-009624
2016-04-2913:00 ETDEF 14AProxy statementPeriod 2016-06-200001171843-16-009524
2016-04-1513:35 ET10-K/AAnnual report, amendedPeriod 2015-12-310001171843-16-009195
2016-03-3017:42 ET10-KAnnual reportPeriod 2015-12-310001171843-16-008925
2016-01-0807:35 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-007107
2015-11-1312:34 ET10-QQuarterly reportPeriod 2015-09-300001171843-15-006315
2015-08-1416:29 ET10-QQuarterly reportPeriod 2015-06-300001171843-15-004723
2015-07-2915:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-15-004162
2015-07-1614:44 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-003871
2015-07-0117:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-003662
2015-06-1812:53 ET10-Q/AQuarterly report, amendedPeriod 2015-03-310001171843-15-003499
2015-06-1117:50 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001171843-15-003386
2015-06-0213:49 ET8-K8.01 Other events0001171843-15-003244
2015-05-2917:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-003213
2015-05-2916:42 ET10-Q/AQuarterly report, amendedPeriod 2015-03-310001171843-15-003210
2015-05-2715:23 ET10-QQuarterly reportPeriod 2015-03-310001171843-15-003134
2015-05-1918:37 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-002935
2015-05-0512:43 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001171843-15-002490
2015-04-2015:03 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-15-138012
2015-04-1019:00 ETS-1/ARegistration statement, amended0001193125-15-124568
2015-03-2715:11 ETS-1/ARegistration statement, amended0001193125-15-109202
2015-03-1016:14 ETS-1/ARegistration statement, amended0001193125-15-085322
2015-02-0206:11 ETS-1Registration statement0001193125-15-028552

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 18:14 ET. Listed shows no prices and gives no investment advice.